Black Rock Inc. Qualigen Therapeutics, Inc. Transaction History

Black Rock Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.46 - $0.93 $35,077 - $70,918	-76,256 Reduced 22.79%	258,419 $147,000
Q1 2022 May 12, 2022	BUY	$0.55 - $1.18 $5,297 - $11,365	9,632 Added 2.96%	334,675 $221,000
Q4 2021 Feb 10, 2022	SELL	$0.94 - $2.56 $6,326 - $17,228	-6,730 Reduced 2.03%	325,043 $347,000
Q3 2021 Nov 09, 2021	SELL	$1.18 - $2.06 $1,925 - $3,361	-1,632 Reduced 0.49%	331,773 $432,000
Q2 2021 Aug 11, 2021	BUY	$1.53 - $2.75 $510,109 - $916,863	333,405 New	333,405 $664,000

Ticker QLGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,795,500
Market Cap $157M
Description
Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, a DNA coated gold nanoparticle cancer drug candidate ...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.